SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 2.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $261,291 | -21.7% | 75,300 | +4.9% | 0.00% | – |
| Q2 2023 | $333,917 | +40.6% | 71,810 | +39.7% | 0.00% | – |
| Q1 2023 | $237,468 | -42.8% | 51,400 | 0.0% | 0.00% | – |
| Q4 2022 | $415,312 | +55.5% | 51,400 | +6.9% | 0.00% | – |
| Q3 2022 | $267,000 | +58.9% | 48,100 | +48.9% | 0.00% | – |
| Q2 2022 | $168,000 | -90.1% | 32,300 | -84.3% | 0.00% | -100.0% |
| Q1 2022 | $1,693,000 | -47.2% | 205,924 | -4.5% | 0.00% | 0.0% |
| Q4 2021 | $3,208,000 | -17.0% | 215,566 | +5.3% | 0.00% | -50.0% |
| Q3 2021 | $3,866,000 | +88.4% | 204,677 | +85.5% | 0.00% | +100.0% |
| Q2 2021 | $2,052,000 | +1.5% | 110,357 | +24.2% | 0.00% | 0.0% |
| Q1 2021 | $2,022,000 | +486.1% | 88,824 | +458.6% | 0.00% | – |
| Q4 2020 | $345,000 | +167.4% | 15,900 | +24.2% | 0.00% | – |
| Q3 2020 | $129,000 | +30.3% | 12,800 | 0.0% | 0.00% | – |
| Q2 2020 | $99,000 | – | 12,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $27,149,000 | 17.55% |
| Samsara BioCapital, LLC | 1,675,579 | $24,933,000 | 4.84% |
| AJU IB Investment Co., Ltd. | 175,000 | $2,604,000 | 3.63% |
| First Light Asset Management, LLC | 2,246,588 | $33,429,000 | 2.39% |
| Opaleye Management Inc. | 680,000 | $10,118,000 | 2.15% |
| FRAZIER MANAGEMENT LLC | 1,776,479 | $26,434,000 | 2.04% |
| Connective Portfolio Management, LLC | 35,000 | $527,000 | 0.93% |
| Parkman Healthcare Partners LLC | 221,219 | $3,292,000 | 0.73% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,437,795 | $36,274,000 | 0.70% |
| Eventide Asset Management | 2,708,975 | $40,310,000 | 0.52% |